Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty
Portfolio Pulse from
Smith+Nephew has launched the CORIOGRAPH Pre-Op Planning and Modeling Services for Total Hip Arthroplasty, approved by the FDA. This service is part of the CORI Surgical System and offers personalized planning for surgeons using X-rays or CT scans.

December 19, 2024 | 3:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Smith+Nephew's new CORIOGRAPH service for hip arthroplasty has received FDA approval, enhancing its CORI Surgical System portfolio. This could improve the company's market position in medical technology.
The FDA approval of the CORIOGRAPH service is a significant development for Smith+Nephew, as it enhances their product offering in the surgical system market. This approval is likely to positively impact their market position and potentially increase sales, leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80